aminolevulinic acid has been researched along with Arterial Occlusive Diseases in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, M | 1 |
| Jamal, W | 1 |
| Mosse, A | 1 |
| Bishop, C | 1 |
| Bown, S | 1 |
| McEwan, J | 1 |
1 other study available for aminolevulinic acid and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Inhibition of in-stent restenosis in rabbit iliac arteries with photodynamic therapy.
Topics: Aminolevulinic Acid; Animals; Arterial Occlusive Diseases; Blood Vessel Prosthesis Implantation; Dis | 2005 |